
Sign up to save your podcasts
Or


Laura Waters, M.D., and Myles Helfand recap several noteworthy moments and clinically important studies from this year's Conference on Retroviruses and Opportunistic Infections (CROI 2025), which took place during a deeply uncertain moment in the HIV field, both domestically and globally. Their research conversation includes highlights in antiretroviral therapy strategies; comorbidities; emerging cure science; and prevention.¶
¶
Access the full transcript, which includes contextual links to study abstracts and other reference info: https://www.thebodypro.com/hiv/future-hiv-care-croi-2025¶
¶
The pod team: Our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.
By TheBodyPro5
77 ratings
Laura Waters, M.D., and Myles Helfand recap several noteworthy moments and clinically important studies from this year's Conference on Retroviruses and Opportunistic Infections (CROI 2025), which took place during a deeply uncertain moment in the HIV field, both domestically and globally. Their research conversation includes highlights in antiretroviral therapy strategies; comorbidities; emerging cure science; and prevention.¶
¶
Access the full transcript, which includes contextual links to study abstracts and other reference info: https://www.thebodypro.com/hiv/future-hiv-care-croi-2025¶
¶
The pod team: Our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.

7,589 Listeners

12,220 Listeners

129 Listeners

261 Listeners

112,031 Listeners

14,907 Listeners

20 Listeners

450 Listeners

19 Listeners

16,606 Listeners

5 Listeners

4,243 Listeners

5 Listeners

7 Listeners

17 Listeners